Zeliang Li

1.3k total citations
43 papers, 975 citations indexed

About

Zeliang Li is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zeliang Li has authored 43 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Zeliang Li's work include Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Zeliang Li is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). Zeliang Li collaborates with scholars based in China, United States and Canada. Zeliang Li's co-authors include Chuize Kong, Jianbin Bi, Xiankui Liu, Yuyan Zhu, Nan Zhou, Meng Yu, Zhibiao Feng, Xingwei Zhang, Yanping Shi and Zhe Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Journal of Colloid and Interface Science.

In The Last Decade

Zeliang Li

41 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeliang Li China 21 560 435 103 93 87 43 975
Qiaoxia Zhang China 21 684 1.2× 293 0.7× 162 1.6× 78 0.8× 71 0.8× 51 1.2k
Yanjun Li China 17 385 0.7× 258 0.6× 45 0.4× 120 1.3× 88 1.0× 45 792
Yuqing Liu China 16 370 0.7× 242 0.6× 62 0.6× 125 1.3× 104 1.2× 56 1.0k
Ming Cao China 19 739 1.3× 464 1.1× 141 1.4× 76 0.8× 116 1.3× 57 1.3k
Shilong Han China 16 700 1.3× 327 0.8× 54 0.5× 49 0.5× 124 1.4× 37 1.3k
Bihui Zhang China 14 227 0.4× 108 0.2× 176 1.7× 141 1.5× 120 1.4× 63 773
Kerong Wu China 16 265 0.5× 79 0.2× 60 0.6× 56 0.6× 122 1.4× 59 617
Chen Wu China 19 1.0k 1.8× 641 1.5× 144 1.4× 111 1.2× 57 0.7× 78 1.5k
Junyu Xiang China 12 374 0.7× 221 0.5× 88 0.9× 15 0.2× 36 0.4× 21 669

Countries citing papers authored by Zeliang Li

Since Specialization
Citations

This map shows the geographic impact of Zeliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeliang Li more than expected).

Fields of papers citing papers by Zeliang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeliang Li. The network helps show where Zeliang Li may publish in the future.

Co-authorship network of co-authors of Zeliang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zeliang Li. A scholar is included among the top collaborators of Zeliang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeliang Li. Zeliang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Dan, Yongqi He, Yajie Li, et al.. (2025). Deep Learning for Staging Periodontitis Using Panoramic Radiographs. Oral Diseases. 31(7). 2273–2281. 1 indexed citations
4.
Deng, Qidu, Syed Comail Abbas, Zeliang Li, et al.. (2020). Chemically modified self-doped biocarbon via novel sulfonation assisted sacrificial template method for high performance flexible all solid-state supercapacitor. Journal of Colloid and Interface Science. 574. 33–42. 69 indexed citations
5.
Zhu, Ye, et al.. (2019). <p>Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice</p>. Drug Design Development and Therapy. Volume 13. 3657–3667. 8 indexed citations
6.
Zhang, Naiwen, Jianyu Yang, Yuyan Zhu, et al.. (2019). Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 111–111. 56 indexed citations
7.
Zhang, Xiaotong, Xi Liu, Jianbin Bi, et al.. (2019). The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer. Cancer Gene Therapy. 27(3-4). 189–202. 23 indexed citations
8.
Li, Zeliang, Xiankui Liu, Jun Li, et al.. (2019). Inhibition of miR‐34a‐5p can rescue disruption of the p53‐DAPK axis to suppress progression of clear cell renal cell carcinoma. Molecular Oncology. 13(10). 2079–2097. 20 indexed citations
9.
Gao, Zhipeng, Xiaojun Man, Zhenhua Li, et al.. (2019). Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma. Oncology Reports. 41(4). 2440–2452. 7 indexed citations
10.
Feng, Zhibiao, et al.. (2018). Fluorescent carbon dots with two absorption bands: luminescence mechanism and ion detection. Journal of Materials Science. 53(9). 6459–6470. 30 indexed citations
11.
Kong, Chuize, et al.. (2017). TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth. Oncology Reports. 38(4). 1967–1976. 36 indexed citations
12.
Zhang, Zhe, Guojun Zhang, Zhipeng Gao, et al.. (2017). Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer. BMC Cancer. 17(1). 861–861. 21 indexed citations
13.
Wang, Hua, Yun Leng, Zeliang Li, et al.. (2011). Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. Biochemical and Biophysical Research Communications. 414(1). 233–239. 91 indexed citations
14.
Li, Zeliang, et al.. (2011). c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells. Urologic Oncology Seminars and Original Investigations. 31(2). 228–233. 6 indexed citations
15.
Zhu, Yuyan, Meng Yu, Zhenhua Li, et al.. (2010). ncRAN, a Newly Identified Long Noncoding RNA, Enhances Human Bladder Tumor Growth, Invasion, and Survival. Urology. 77(2). 510.e1–510.e5. 82 indexed citations
16.
Zhang, Zhe, et al.. (2010). Up-regulation of glucosylceramide synthase in urinary bladder neoplasms. Urologic Oncology Seminars and Original Investigations. 30(4). 444–449. 16 indexed citations
17.
Kong, Chuize, et al.. (2007). [Study on multiple aldosterone-producing adenomas].. PubMed. 45(24). 1701–3. 1 indexed citations
18.
Zhang, Chen‐Ou, Zeliang Li, & Chuize Kong. (2005). APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis. BMC Urology. 5(1). 7–7. 39 indexed citations
19.
Zhu, Yuyan, Haiming Wang, Chuize Kong, et al.. (2005). [The role of protein kinase C alpha in recurrence of superficial bladder carcinoma].. PubMed. 43(10). 662–6. 1 indexed citations
20.
Kong, Chuize, et al.. (2005). Inhibition of tumor angiogenesis during cisplatin chemotherapy for bladder cancer improves treatment outcome. Urology. 65(2). 395–399. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026